Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-13 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-08 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.23 | 5e-08 |
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.25 | 8e-08 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-07 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-06 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-06 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |